Description
BSE announces listing of 20,75,073 new equity shares of Vivo Bio Tech Ltd issued through warrant conversion, effective August 18, 2025.
Summary
BSE has announced the listing of 20,75,073 new equity shares of Vivo Bio Tech Ltd (Scrip Code: 511509) issued through conversion of warrants on a preferential basis to non-promoters. The shares will commence trading on August 18, 2025.
Key Points
- 20,75,073 equity shares of Rs. 10 each issued at premium of Rs. 35 to non-promoters
- Shares issued through preferential allotment pursuant to warrant conversion
- Issue price: Rs. 45 per share
- Distribution numbers: 17924817 to 19999889
- ISIN: INE380K01017
- Shares rank pari-passu with existing equity shares
Regulatory Changes
No regulatory changes - routine listing process for warrant conversion.
Compliance Requirements
- Trading members informed of new securities listing
- Lock-in period applicable as per SEBI regulations
- All shares subject to lock-in until February 28, 2026
Important Dates
- Allotment dates: May 28, June 18, June 25, July 3, 2025
- Trading commencement: August 18, 2025
- Lock-in expiry: February 28, 2026
Impact Assessment
Minimal market impact as this is a routine listing of securities from warrant conversion. The lock-in period until February 2026 prevents immediate trading of these shares, limiting short-term supply impact.
Impact Justification
Routine listing announcement for a single company with limited market impact